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RESEARCH ARTICLE
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Abstract
This study investigated the relationship between host efflux system of the non-vertebrate
nematode Caenorhabditis elegans and Burkholderia cepacia complex (Bcc) strain virulence. This is the first comprehensive effort to profile host-transporters within the context of
Bcc infection. With this aim, two different toxicity tests were performed: a slow killing assay
that monitors mortality of the host by intestinal colonization and a fast killing assay that
assesses production of toxins. A Virulence Ranking scheme was defined, that expressed
the toxicity of the Bcc panel members, based on the percentage of surviving worms.
According to this ranking the 18 Bcc strains were divided in 4 distinct groups. Only the Cystic Fibrosis isolated strains possessed profound nematode killing ability to accumulate in
worms’ intestines. For the transporter analysis a complete set of isogenic nematode single
Multidrug Resistance associated Protein (MRP) efflux mutants and a number of efflux inhibitors were interrogated in the host toxicity assays. The Bcc pathogenicity profile of the 7 isogenic C. elegans MRP knock-out strains functionality was classified in two distinct groups.
Disabling host transporters enhanced nematode mortality more than 50% in 5 out of 7
mutants when compared to wild type. In particular mrp-2 was the most susceptible phenotype with increased mortality for 13 out 18 Bcc strains, whereas mrp-3 and mrp-4 knockouts had lower mortality rates, suggesting a different role in toxin-substrate recognition. The
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use of MRP efflux inhibitors in the assays resulted in substantially increased (>40% on average) mortality of wild-type worms.

Introduction
The Burkholderia cepacia complex (Bcc) occupies a critical position among Gram-negative
multi-drug resistant bacteria. It consists of at least 20 closely related species inhabiting different
ecological niches, including plants and animals [1–5]. Bcc multi drug and pandrug-resistant
opportunistic human pathogens cause problematic lung infections in immune-compromised
individuals, including cystic fibrosis (CF) patients [6–8]. Bcc members are naturally resistant
to antibiotics including cephalosporins, β-lactams, polymyxins and aminoglycosides, rendering
Bcc infections challenging to eradicate [9,10]. There is an imminent need to develop new Bcc
antimicrobial therapeutic strategies. Dissecting virulence and pathogenicity determinants as
well as identifying novel therapeutic targets may be promising approaches. These tasks may be
advanced by the exploitation of the non-vertebrate host models Drosophila melanogaster, Galleria mellonella, and Caenorhabditis elegans. Model hosts have been used to evaluate microbial
virulence traits involved in mammalian infections and the efficacy of antimicrobial compounds
[11–16]. The free-living nematode C. elegans is a widespread multicellular organism that is a
self-fertilizing hermaphrodite with a rapid generation time. C. elegans has been proven costeffective, ethical, reproducible and genetically powerful infection model despite the obvious
reported technical limitations (nematodes have lower optimal growth temperatures when compared with human pathogens; occurrence of host specific virulence factors) [15,17–19]. In fact,
there is an extensive body of literature for the utility of the nematode to model infection with a
variety of Gram-negative bacteria including Escherichia coli, Burkholderia pseudomallei, B.
cepacia complex and Pseudomonas aeruginosa [20–23]. The C. elegans-Bcc studies in the last
decade have shed some light on the complex-nematode interaction, correlating genotypic characteristics of the pathogen with phenotypic changes in the host. These efforts have identified
specific virulence factors: the auto inducer dependent Acyl-HomeSerineLactone (aidA), the
phenazine biosynthesis regulator (Pbr), and the host factor phage Q, (hfq) [16,24–33].
Recent studies have underlined the importance of efflux systems in infection within the content of host-pathogen interaction [34–36]. The host efflux capability is considered part of a
basic defence mechanism. For example the B. pseudomallei infection stimulates the overproduction of the ATP Binding Cassette (ABC) transporter pgp-5 in C. elegans [37]. However, the
partition of host transporters in the infection process has never been studied in depth. Bcc
members produce a variety of metabolites and toxins, potential host efflux substrates. Furthermore, exploring the role of host transporters in pathogenicity may facilitate the design of
appropriate tools for toxin identification. Multidrug Resistance associated Proteins (MRPs) are
members of the ABC efflux transporter family with broad substrate specificity for the transport
of endogenous and xenobiotic anionic substances found in Bacteria, Archaea and Eukarya [38–
41]. MRPs play important roles in nematode physiology such as control resistance to anthelmintic (ivermectine) and heavy metals (arsenic) [42–44]. This study emphasizes the contribution of the host MRP efflux subfamily to Bcc virulence, employing a panel of 18 strains
representing the up-to-date different acknowledged species and a fully functional seven single
C. elegans mutant set impaired in MRPs. A Virulence-Ranking (VR) scheme based on comparing host survival rates in two different assays was developed. This scheme provides the tool for
a detailed study on the effect of the MRP transporter family on Bcc virulence using as well as
selected efflux inhibitors.

PLOS ONE | DOI:10.1371/journal.pone.0142883 November 20, 2015

2 / 17

Role of MRPs in Bcc Pathogenicity Using C. elegans as Infection Model

Materials and Methods
Bacterial strains, nematode strains and growth conditions
C. elegans Wild-type (WT) Bristol N2, NL147 (mrp-1(pk89) X), RB1713 (mrp-2(ok2157) X),
RB1028 (mrp-3(ok955) X), VC712 (mrp-4(ok1095) X), VC1599 (mrp-5(ok2067)/szT1 X),
RB1070 (mrp-6(ok1027) X) and RB1269 (mrp-8(ok1360) III) strains were obtained from the
Caenorhabditis Genetic Centre (CGC). For strain VC1599, due to ok2067 mutation lethality
in homozygosis, all the experiments were performed assaying heterozygotes worms. All
mutants presented identical phenotypic traits in respect to WT: normal larval development
(eggs reaching adults state in 72 h as indicated on standard table (www.wormbook.org)),
non-impaired reproduction, and survival rate at 100% when fed with E. coli. Mutant mpr-5
in heterozygosis also aligned to those parameters. All strains were recovered from frozen
stocks, and routinely kept on NGM (Nematode Growth Medium) plates seeded with E. coli
OP50 as a food source [45]. The panel of Bcc strains used in this work belongs to the Bcc collection at the University of Gent, Belgium, and is listed in Table 1. Bcc and E. coli OP50 cells
were routinely grown in Luria-Bertani broth (LB) (10 g/L Bacto-tryptone, 5 g/L Yeast extract,
10 g/L NaCl) at 37°C.

Nematode Toxicity Assays
Slow Killing Assay (SKA) was performed against the C. elegans WT strain N and MRPmutants. 2.5-cm-diameter plates containing 3 ml of NGM agar (Peptone 2.5 g/L, NaCl 2,9 g/L,
Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4 25 mM, MgSO4 1 mM) were
seeded with 50 μl of the overnight Bcc cultures, normalized to an OD600, of 1.7 and incubated
for 24 h at 37°C to allow the formation of a bacterial lawn. This was the standard bacterial
growth condition unless otherwise stated. C. elegans WT strain and MRP-mutants were synchronized by bleaching treatment [46], and 30–40 worms at larval stage 4 (L4), were transferred to each plate and incubated at 20°C for three days. The plates were scored for living
worms every 24 h.
Fast Killing assay (FKA) was carried out in 2.5-cm-diameter plates containing 3 ml of
Peptone Glucose Sorbitol (PGS) agar medium [25] (Peptone 12 g/L, Glucose 12 g/L, Sorbitol
27.25 g/L, NaCl 12 g/L, Bacto-Agar 17 g/L, CaCl2 1 mM, Cholesterol 5 μg/mL, KH2PO4
25 mM, MgSO4 1 mM). Plates were prepared as described above for the SKA. Then, L4
worms from WT strain and MRP-mutants were collected from NGM plates, washed with M9
medium (Na2HPO47H2O 12.8 g/L, Na2HPO4 (anhydrous) 6 g/L, KH2PO4 3 g/L, NaCl
0.5 g/L, NH4Cl 1 g/L) and 30–40 L4 worms were spotted onto the bacterial lawn. The plates
were then incubated at 20°C and scored for living worms every 24 h. In both assays, E. coli
OP50 was used as a negative control. A worm was considered dead when it no longer
responded to touch. For statistical purposes, 5 replicates per trial were carried out with a
unique egg preparation. The incubation time was set at 2 days. A pathogenicity scheme (VR)
was established by comparing the "infectivity" towards nematodes between E. coli OP50 and
Bcc isolates.

Microscopy analysis
40–60 WT L4 worms were grown on NGM plates seeded with Bcc or E. coli OP50 propagated
in standard growth conditions. Plates were incubated at 20°C, and after 4 and 24 h, the nematodes were inspected using a Zeiss Axioskop microscope equipped with Differential Interference Contrast (DIC) employing 10x, 20x, 40x, 63x and 100x objectives and 10X eyepiece.
Images were collected with a Zeiss Axiocam MR digital camera.
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Table 1. Burkholderia cepacia complex used in this work and VR relative to the different killing assays.
Species

Strain

Source

SKA

FKA

LMG 1222

Onion

0

3

Burkholderia multivorans

LMG
13010

CF

0

0

Burkholderia cenocepacia

LMG
16656

CF

2

2

Burkholderia stabilis

LMG
14294

CF

3

3

Burkholderia vietnamiensis

LMG
10929

Soil

1

0

Burkholderia dolosa

LMG
18943

CF

0

1

Burkholderia ambifaria

LMG
19182

Soil

0

3

Burkholderia anthina

LMG
20980

Soil

2

1

Burkholderia pyrrocinia

LMG
14191

Soil

0

2

Burkholderia ubonensis

LMG
20358

Soil

2

1

Burkholderia latens

LMG
24064

CF

1

1

Burkholderia diffusa

LMG
24065

CF

2

2

Burkholderia arboris

LMG
24066

Soil

1

1

Burkholderia seminalis

LMG
24067

CF

2

2

Burkholderia metallica

LMG
24068

CF

3

3

Burkholderia lata

LMG
22485

Soil

0

1

Burkholderia contaminans

LMG
23361

AI

1

3

Burkholderia
pseudomultivorans

LMG
26883

CF

0

1

Burkholderia cepacia

Abbreviations: Soil = Soil rhizosphere, AI = Animal Infections, CF = Cystic Fibrosis patients
VRs
0 = 100% > Survival worms > 80%
1 = 79% > Survival worms > 50%
2 = 49% > Survival worms > 6%
3 = 5% > Survival worms > 0%
doi:10.1371/journal.pone.0142883.t001

Toxin Diffusion assay
Bcc or E. coli OP50 cells were grown under standard growth conditions and spread on sterile
0.22 μm Millipore Nitrocellulose (Darmstadt, Germany) filter disk located onto 2.5-cm-diameter PGS plates [25]. After overnight incubation at 37°C, the filter together with the bacterial
lawn was removed and the plates were allowed to cool to room temperature. 30–40 hypochlorite-synchronised WT L4 nematodes were spotted onto the conditioned agar. Paralysation and
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mortality of the worms were detected at 4 and 24 h. The experiments were performed in triplicate, and data reported are mean values ± SD.

Statistical analysis and clustering
All the Kaplan-Meier survival curves were analyzed using the Graph-pad Prism 5 software.
Comparisons vs. control for both the C. elegans and inhibitor experiments were performed
using Fisher’s exact test to account for possible non-Normality in the data. In particular, as it
was observed that replicate means of C. elegans percent mortality correlated extremely well to
pooled percent mortality (R2 > 0.99 in all cases), counts of C. elegans that were alive and dead
after 72 h were used to populate the various 2x2 tables onto which the Fisher’s exact test was
applied. Bonferroni-Holm correction of p-values was used to account for the multiple comparisons performed.
Mutant clustering analysis was performed using hierarchical clustering via Ward’s method.
Clusters were fixed using a consistency threshold of 1.1, resulting in cophenetic coefficient
(correlation between cluster and metric distance) of at least 0.80.

Transporter Inhibitor assays
The MRP transporter inhibitors mometasone furoate, lasalocid A sodium, verapamil hydrochloride were purchased from Sigma-Aldrich, Saint Louis, MO. Compounds were dissolved in
DMSO and spread onto NGM plates in different concentration ranges: 25–100 μM (mometasone and verapamil) and 125–500 nM (lasalocid). DMSO (0,5% w/v) was used as control. Subsequently, Bcc strains (grown in standard conditions) were spotted onto the plates that were
incubated overnight at 37°C. After the incubation 30–40 WT L4 worms were spotted onto the
bacterial lawn. The plates were then incubated at 20°C for 3 days and scored for living worms
every 24 h. The experiments were performed in triplicate, and the data reported are mean
values.

Results and Discussion
Killing of C. elegans by Bcc strains
To evaluate Bcc virulence determinants and properties, two different assays were performed: i)
SKA, performed on a low osmolarity medium (NGM), assigned to correlate worms mortality
with intestinal bacterial accumulation/colonisation [24,25]; ii) FKA carried out on a high
osmolarity medium (PGS) to demonstrate the secretion of bacterial toxins and evaluate their
capacity to paralyse and kill the nematodes [24,25]. A VR was established for the Bcc strains
under investigation by comparing the "infectivity" against nematodes between E. coli OP50 and
Bcc isolates. The VR ranges from 0 to 3 (see Fig 1) and was based on the percentage of surviving worms after the period of observation, which was set at 3 days. A Bcc strain was considered
to be non-pathogenic (VR = 0) when no symptom of disease was observed during the course of
nematodes infection and the percentage of live worms at the conclusion of the period of observation ranged from 100 to 80%; VR = 1 corresponded to a percentage of alive worms between
79 to 50%; VR = 2 corresponded to a percentage of alive worms between 49 to 6%; finally, the
VR was considered 3 when the percentage of surviving worms was  5%.
SKA performed against WT L4 worms revealed diverse pathogenicity capabilities among
the 18 Bcc representatives [Table 1]:
i. 2 Bcc strains (B. metallica, B. stabilis) displayed high nematocide activity (VR 3). No viable
nematodes were detectable in the plates after 3 days of incubation at 20°C.
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Fig 1. Kaplan-Meier survival plots for L4 N2 worms fed with exemplifying Bcc strains for different VR grown on PGS medium. Worms fed on: B.
metallica (VR 3; black line; n = 113; 0% survival at day 2); B. seminalis (VR 2; blue line; n = 150; 34% survival at day 2); B. dolosa (VR 1; redline; n = 198; 69%
survival at day 2); B. multivorans (VR 0; green line; n = 120; 93% survival worms). n: Number of worms at day 0. All p-values, comparing each survival curve
between them, resulted to be < 0.0001, calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
doi:10.1371/journal.pone.0142883.g001

ii. Half of the Bcc strains exhibited VR between 1 and 2, showing an intermediate toxicity
towards C. elegans.
iii. Seven Bcc strains (B. ambifaria, B. cepacia, B. dolosa, B. pseudomultivorans, B. pyrrocinia,
B. lata and B. multivorans) were unable to kill worms, and the whole population was viable
(VR = 0).
Nematodes killed in the lawn of bacteria took on a ghostly and hollow “shell-like” appearance about 48 h after the L4 were first introduced, and their shells induced by B. ubonensis, B.
metallica and B. stabilis were defined as “chalk-mark ghosts”. This shape is characteristic of
organisms lacking a discernible internal cell structures. Often the ghosts eroded to a mere
outline.
The pathogenicity of the 18 Bcc strains was then assessed on FKA. Data obtained are summarised in Table 1. Nematodes death on FKA appeared to be a rapid process as they loose
locomotor functions, as shown by the quick onset of lethargy. Motility visibly decreased after
exposure for 4 h, and the rate of foraging was similarly affected in the same time frame. In
FKA, five strains (B. ambifaria, B. cepacia, B. contaminans, B. metallica, B. stabilis) demonstrated deep killing ability (VR = 3) against C. elegans and only two strains (B. multivorans and
B. vietnamiensis) were completely ineffective in killing worms. For the highly active strains,
almost 100% mortality occurred in 24 h, while on SKA 3 days are required for complete killing
(Fig 2).
Nine out of 18 Bcc strains have previously been characterized using SKA [30,47]. The VR of
7 strains (B. anthina, B. ubonensis, B. vietnamiensis, B. cenocepacia B. dolosa B. ambifaria, B.
cepacia) are consistent with the previously reported SKA ranking. The same comparison
revealed a variation for B. pyrrocinia and B. stabilis, which were found as more and less

PLOS ONE | DOI:10.1371/journal.pone.0142883 November 20, 2015

6 / 17

Role of MRPs in Bcc Pathogenicity Using C. elegans as Infection Model

Fig 2. Kaplan-Meier survival plots for L4 stage WT worms fed with: E. coli OP50 (solid lines), Bcc strains on NGM (dashed lines), Bcc strains on
PGS (dotted lines). n: Number of worms at day 0. A) The pathogenicity of Bcc strain B. cepacia on SKA (n = 93) was compared with the ability on FKA
(n = 184). B) The pathogenicity of Bcc strain B. metallica on SKA (n = 80) was compared with the ability on FKA (n = 113). C) The pathogenicity of Bcc strain
B. stabilis on SKA (n = 87) was compared with the ability on FKA (n = 161). P-values were calculated between survival curves on FKA and SKA of each
bacteria, and resulted to be < 0.0001 calculated with "Log-rank (Mantel-Cox) Test" with the Graph-pad Prism 5 software.
doi:10.1371/journal.pone.0142883.g002

virulent, respectively. This variability may be due to ranking differences, as the experimental
conditions were very reproducible. This is the first report for an indicative pathogenicity ranking for 8 Burkholderia species, recently added to Bcc, (B. latens, B. diffusa, B. arboris, B. seminalis, B. metallica, B. pseudomultivorans, B. lata, B. contaminans). B. metallica, B. stabilis (both
isolated from CF patients) were the most virulent in both assays (Fig 2B and 2C). The comparison of data obtained in the FKA and SKA revealed that, on average, strains isolated from CF
patients appeared more virulent than environmental isolates on SKA. In particular, three Bcc
strains (B. ambifaria, B. cepacia and B. pyrrocinia) exhibited high nematocide activity in the
FKA, whereas they were unable to kill the worms in the SKA (VR 0 and 1). Therefore we can
assume that toxin production is a common virulence mechanism for Bcc members, while CF
isolates might have acquired different pathogenic traits that allow them to infect and colonize
hosts, as already proposed by Pirone et al. [48]. The only exception is represented by B. multivorans, and B. pseudomultivorans. These two strains are CF isolates, but were non-virulent
towards nematodes. This evidence likely rely in the limitation of the nematode host model,
once more indicating that virulence factors are not universal for all hosts [15].
Bacterial intestinal accumulation. The two Bcc strains with VR = 3 in the SKA (B. stabilis
and B. metallica) were then assessed for their ability to accumulate in the C. elegans intestine.
Worms grown in standard condition were inspected using a compound microscope at different
incubation times to evaluate the bacterial accumulation in the intestinal lumen.
Bcc colonization of nematode occurred rapidly. After 4 h of incubation, worms fed with E.
coli OP50 showed a thin intestinal lumen (Fig 3A and 3B), whereas, when spotted onto B.
metallica layer, worms already presented deformed intestines (Fig 3E). After 24 h nematodes
displayed a full intestinal lumen packed with bacteria (Fig 3F). These data confirmed that Bcc
with high VR were able to accumulate within the entire nematode intestine and therefore slowkilling may resemble an infection-like process. On the contrary, nematodes exposed to the
strain B. pseudomultivorans, which exhibited a low pathogenicity (VR = 0 on SKA), under the
same experimental conditions presented a healthy intestine with the presence of bacterial cells
only in the first part of the intestine (Fig 3C and 3D). This finding may signify that: i) even
non-pathogenic Bcc strains were able to pass intact through the pharynx and occupy the
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Fig 3. The ability of Bcc strains to accumulate in C. elegans intestinal lumen was evaluated with microscopy analysis. Red arrows indicate the
nematodes intestine. A) Intestinal lumen of one L4 stage WT worm after 4 h of incubation on NGM plate spotted with E. coli OP50, and B) after 24 h of

PLOS ONE | DOI:10.1371/journal.pone.0142883 November 20, 2015
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incubation on the same plate. C) Intestinal lumen of one L4 WT after 4 h of incubation on NGM plate spotted with B. pseudomultivorans (VR 0 on SKA, and D)
after 24 h of incubation on the same plate. E) Intestinal lumen of one L4 WT after 4 h of incubation on NGM plate spotted with B. metallica (VR 3 on SKA, and
F) after 24 h of incubation on the same plate.
doi:10.1371/journal.pone.0142883.g003

intestine; ii) the accumulation of the Bcc in the whole nematode gut, especially in the last part
of the intestine, might be responsible for the worm’s death [24].
Toxin Diffusion assay. To evaluate the contribution of diffusible secreted factors (toxins
and/or other virulence chemical signalling molecules) to the rapid kinetics of killing on FKA,
we performed the toxin diffusion assay [25]. These experiments were carried out on a reduced
panel consisting of the five Bcc strains possessing the highest nematocide activity on FKA (B.
contaminans, B. cepacia, B. ambifaria, B. metallica and B. stabilis). Results shown in Fig 4
revealed that a high percentage of worms were paralyzed after 4 h of incubation on plates, even
if they were not in contact with the bacteria. In particular, only 30% of the worms placed on B.
ambifaria plates were still mobile and active, whereas the remaining nematode population
appeared paralysed. On the contrary, worms spotted on plates containing E. coli conditioned
agar did not present any paralysis or mortality. Among the tested Bcc strains, B. ambifaria was
the most active toxin producer. Indeed, after 24 h of incubation only 20% of the total number
of nematodes was still moving on B. ambifaria plates (Fig 4). In the case of B. stabilis, it was
observed that paralyzed worms at 4 h were able to move again and survive. One plausible
explanation for this variation might be related to low stability of the diffusible toxins/virulence
determinants produced by those strains that require constant production.
Interestingly, when the toxin filter assay was performed on NGM medium, no paralysis or
mortality was detected. This experiment confirms that FKA rapid killing kinetics revealed a
role for diffusible toxins as a main component of the infectious process. Thomson and Dennis
demonstrated the production by Bcc strains of a haemolytic toxin required for full virulence,
synthesized by a non-ribosomal peptide synthase (NRPS) pathway, typical of a complex secondary metabolite [49]. They screened a panel of Bcc strains including B. cenocepacia, B. stabilis, B. pyrrocinia and B. vietnamiensis for the presence of this gene cluster. A NRPS cluster was
identified in B. pyrrocinia and B. stabilis with VR = 3 on FKA. Moreover, Bcc strains are
known to produce toxins with demonstrated antifungal activity like the cyclic peptides occidiofungins (burkholdines) [50]. Therefore, we cannot a priori exclude the possibility that a peptide
might represent the toxin active towards C. elegans.

Killing of MRPs knock-out C. elegans mutants by Bcc member strains
The nematode-Bcc pathogenicity ranking system developed was investigated for its ability to
detect and map genotype-specific host responses. We obtained access to a complete, seven
MRPs knock-out nematode mutant set, mrp-1(pk89), mrp-2(ok2157), mrp-3(ok955), mrp-4
(ok1095), mrp-5(ok2067), mrp-6(ok1027) and mrp-8(ok1360), impaired in the corresponding
ABC membrane transporters.
These knock-out mutants exhibited identical phenotypic attributes with the WT. The 18
Bcc representative strains were profiled against the 7 mutants in both SKA and FKA. Control
mortality was calculated to be the number of dead worms divided by the number of total
worms. Pooled mortality counts (alive vs. dead) for each mutant were tested against the WT
using Fisher’s Exact test. Statistically significant (Bonferroni-Holm corrected p-value < 0.05)
differences from WT are shown in Table 2. The mortality rates calculated were highly variable
suggesting a Bcc strain-specific effect towards the MRP C. elegans mutants. Some trends were
detected: mrp-5 and mrp-2 had increased mortality rate for several Bcc strains in both SKA and
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Fig 4. Secreted compounds or toxins mediate fast killing. Data reports paralysis and mortality at 4 and 24 h of worms plated on PGS medium plates
treated with Bcc strains or E. coli grown on a sterile disk. Data represent mean values of three independent experiments and SD values are reported. Pvalues were calculated between sample (Bcc) and control (OP50) at the corresponding time, and were always < 0.05.
doi:10.1371/journal.pone.0142883.g004

FKA. Specifically, 8 Bcc strains in SKA and 9 in FKA showed increased killing towards mrp-5,
while 8 strains in SKA and 8 in FKA appeared more virulent against mrp-2. C. elegans mutants
mrp-3 and mrp-4 displayed lower killing rates when incubated with several Bcc strains. In particular, mutant mrp-4 exhibited decreased mortality to 8 Bcc species in SKA and to 7 strains in
FKA. Regarding the Bcc strains, on SKA B. ambifaria displayed increased virulence towards
the whole mutant set, with mortality rate compared to the WT higher than 75% and 71%
towards, mrp-5 and mrp-6 respectively. B. arboris demonstrated an increased pathogenic effect
towards mrp-1, mrp-2, mrp-6, mrp-8, while B. dolosa was more lethal against mrp-2, mrp-5,
mrp-6, mrp-8 mutants. On FKA, B. lata and B. multivorans were the most pathogenic strains
with increased mortality rate against all mutants, while B. diffusa was more virulent against 6
mutants, and B. arboris against 5 mutants.
The complete set of killing results for each Bcc strain generated a unique killing profile in
each MRP mutant. To determine whether these profiles constitute a coherent mutant classification pattern, a hierarchical clustering of significant effect sizes vs. each strain (Ward’s method,
Consistency Threshold 1.1) was performed. This analysis showed different patterns for mrp-3
and mrp-4 when compared with the rest of MRP-phenotypes in both FKA and SKA. However,
mrp-3 and mrp-4 share low sequence identity/similarity among them (data not shown), suggesting that these two transporters do not have similar substrate specificity or function. These
MRP-phenotypes were grouped consistently and differentiated from the rest of single knock
out strains (Fig 5). This pattern could justify the diverse phenotypic response to Bcc of the
MRP knock-out mutants, indicating variation in substrate profile specificity for the 7 MRP
efflux systems. The clustering patterns of the other transporters suggest distinct substrate specificity, in agreement with the low degree of sequence identity/similarity shared among them
(data not shown). Nevertheless, we can assume that toxins and small molecules are MRPrelated substrates, and these transporters play a fundamental role in Bcc defence, with the
exception of mrp-3 and mpr-4.
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Table 2. MRP knock-out C. elegans mutants mortality expressed as percentage of dead worms and comparison between the mutants and the WT.
Mutant mrp-5 was tested as heterozygote, due to lethality of the mutation in homozygosis. Statistical significant differences appear highlighted, with negative
values indicating statistically significant reductions in mortality from WT, and with positive values indicating statistically significant increases in mortality from
WT.
Signiﬁcant Changes in % Mortality
Strain

WT Mortality FKA

mrp-1

mrp-2

mrp-3

mrp-4

mrp-5

mrp-6

mrp-8

B. ambifaria

95

NS

-27

NS

NS

NS

NS

NS

B. anthina

42

45

50

NS

NS

58

NS

NS

B. arboris

28

70

72

21

NS

NS

72

72

B. cenocepacia

64

NS

31

NS

-45

NS

27

NS

B. cepacia

100

-19

NS

NS

-19

NS

-15

-18

B. contaminans

94

NS

NS

-17

-16

NS

NS

NS

B. diffusa

69

NS

NS

NS

NS

NS

NS

-26

B. dolosa

31

33

NS

59

NS

48

49

NS

B. latens

42

NS

NS

-34

NS

38

NS

-28

B. metallica

100

NS

NS

-13

-17

NS

NS

-10

B. pseudomultivorans

20

NS

NS

NS

NS

50

NS

NS

B. pyrrocinia

70

NS

21

-44

-35

26

NS

29

B. seminalis

64

NS

NS

-44

-31

NS

NS

NS

B. stabilis

100

-9

-47

NS

NS

-10

-63%

-77%

B. ubonensis

52

NS

41

NS

-24%

38

NS

32

B. vietnamiensis

14

NS

40

-12%

NS

57

61

35

B. lata

18

38

64

27

42

70

54

53

B. multivorans

7

33

22

21

34

62

28

45
mrp-8

Strain

WT Mortality SKA

mrp-1

mrp-2

mrp-3

mrp-4

mrp-5

mrp-6

B. ambifaria

6

61

67

30

28

75

71

58

B. anthina

91

9

NS

-27

-24

NS

NS

NS

B. arboris

46

53

54

-35

NS

NS

50

51

B. cenocepacia

81

NS

NS

NS

-77

-65

-24

-54

B. cepacia

9

81

75

NS

NS

78

62

45

B. contaminans

47

30

26

49

NS

NS

NS

NS

B. diffusa

88

NS

NS

NS

-25

NS

NS

NS

B. dolosa

13

NS

25

NS

NS

61

61

28

B. latens

22

NS

43

-19

-19

46

NS

42

B. metallica

100

NS

NS

-14%

-8%

NS

NS

NS

B. pseudomultivorans

11

NS

NS

NS

NS

30

NS

NS

B. pyrrocinia

5

53

61

NS

NS

64

57

46

B. seminalis

69

28

NS

-50

-67

NS

NS

NS

B. stabilis

100

-90

-58

NS

NS

-55

-60

-84

B. ubonensis

83

-60

NS

-28

-36

NS

NS

NS

B. vietnamiensis

46

-44

-39

-43

-44

-34

50

-41

B. lata

10

NS

NS

NS

NS

52

NS

NS

B. multivorans

3

NS

22

NS

NS

35

41

NS

NS = Not signiﬁcant difference
doi:10.1371/journal.pone.0142883.t002

Inhibitor experiments
The Bcc pathogenicity ranking system was used to facilitate testing for a distinct MRP-efflux
system substrate profile within the content of infection. Disabling efflux pumps genetically
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Fig 5. Hierarchical Clusterings. Ward’s method with a consistency threshold 1.1 used to cluster mutants based on significant changes in pathogenicity.
doi:10.1371/journal.pone.0142883.g005

(knock-outs) or chemically (small molecules-inhibitors) should have a similar toll on increasing nematode mortality. A pilot analysis was performed utilizing the Bcc strains that exhibited
increased C. elegans susceptibility in numerous efflux knock-outs on SKA (B. ambifaria, B.
arboris, B. cepacia, B. dolosa, B. pyrrocinia) and the well-characterized mammalian MRP-efflux
inhibitors mometasone furoate, lasalocid A and verapamil [51]. All compounds did not affect
Bcc or C. elegans viability at the concentration used for the assay, (S1 Fig) The compounds
were spread in concentration ranges onto NGM plates to perform SKA and DMSO (0.5%) was
used as a growth control. Control mortality was calculated to be the number of dead worms
divided by the number of total worms. Comparison to solvent control of pooled mortality
counts was done using Fisher’s Exact test; results were considered significant if BonferroniHolm corrected p-values were less than 0.05. Statistically significant differences from the WT
are shown in Table 3. Reduction in mortality from the controls was not observed. The inhibitor
use in the infection system, provided a statistically significant increase of mortality in the presence of at least one inhibitor compared to DMSO controls for 3 Bcc strains, whereas B. pyrrocinia and B. ambifaria killing rates were not affected.
In particular, the presence of mometasone (100 μM), B. arboris, B. cepacia and B. dolosa
enhanced virulence against nematodes with mortality rate of 40% higher than the control.
Lasalocid (500 nM) caused an increase in the percentage of dead worms of 34% and 48%

Table 3. Effect of ABC inhibitors during C. elegans- Bcc infection on SKA. Nematodes mortality expressed as percentage of dead worms and compared between samples with inhibitors and control with DMSO (0,5%). Statistical significant differences were reported.
Signiﬁcant Changes in % Mortality
Strain

Control Mortality

Verapamil

Mometasone

Lasalocid

100 μM

50 μM

25 μM

100 μM

50 μM

25 μM

500 nM

250 nM

125 nM
NS

B. cepacia

17

NS

NS

NS

45

NS

NS

34

NS

B. arboris

20

35

NS

27

45

NS

NS

NS

NS

NS

B. dolosa

32

NS

NS

NS

44

29

NS

48

38

NS

NS = Not signiﬁcant difference
doi:10.1371/journal.pone.0142883.t003
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with B. cepacia and B. dolosa, respectively. Verapamil (100 μM) enhanced killing only for B.
arboris, with a killing rate of 35% higher than the control. These results demonstrated that
the inhibitor driven MRP transporter inactivation results in increased mortality at least for
two inhibitors, of the nematodes to Bcc strains, supporting the role of these transporters in
Bcc infection. Verapamil has been characterized as a competitive inhibitor in ABCB1 malignant cell overexpression [52] as wells as a potent ABCC family inhibitor [53]. It is also
involved in inhibiting C. elegans P-gp1, which is involved in nematode resistance to ivermectine [54]. The present experimental setup differs as it explores verapamil against a number of
targets simultaneously not by isolating transporters of interest. This analysis suggests that
verapamil very likely works, but the number of interactions leading to a weaker phenotype
should be investigated further.

Conclusions
The major aim of this work was to inquire the role of host transporters in the infection developing a nematode virulence ranking system focusing in well-recognized Bcc strains. It is common knowledge that every bacterial species includes member-strains with different pathogenic
characteristics. However, the key purpose was to build the model using type strains of each of
the 18 currently known Bcc species, a combination of two different killing assays (SKA and
FKA), and a set of nematode mutants impaired in MRP efflux transporters. We focused on
type strains due to the extensive information known, as many Bcc genomes have been
completely sequenced and more will be soon become available. To define Bcc virulence we
established a VR scheme, based on the percentage of surviving worms. Both nematocidal assays
revealed different pathogenicity profiles for the Bcc species. Strains with high score in the VR
system were able to accumulate in the nematodes intestine and produce virulence factors, on
SKA and FKA, respectively. Only Bcc CF isolates accumulate within worms, an observation
that correlates well with the apparent differences in virulence factors between environmental
and CF isolates. This VR scheme was applied to profile Bcc pathogenesis in seven MRP
impaired C. elegans mutants. MRPs are implicated in distinct nematode cellular processes:
MRP1 is involved in heavy metal tolerance and ivermectine resistance [42,43]; MRP4 is central
in early-stage differentiation [55]; MRP5 acts as a fundamental heme exporter into embryonic
development [56]. Results showed increased nematode mortality for several C. elegans mutants
grown in the presence of specific Bcc strains compared to WT nematodes. In particular mrp-2
and mrp-5 were the most susceptible mutants with increased mortality respectively in 13 and
11 different Bcc strains in the two assays, suggesting an active role of these two efflux transporters in host defense. However strain mpr-5 was tested only in heterozygosis and this could have
affected survival rate. Cluster analysis consistently grouped and separated mrp-3 and mrp-4
mutants in both assays from the other MRP-phenotypes. This pattern suggested different substrate specificity for these MRP transporters. To further explore the role of MRP transporters
in host defense, inhibitor experiments were carried out on a selected panel of the five most
"infectious" Bcc strains against the MRP knock-out mutants (B. ambifaria, B. arboris, B. cepacia, B. dolosa, B. pyrrocinia). These strains were tested against the WT nematodes in the presence of three well-characterized MRP-inhibitors, with a broad inhibitory activity against MRP
transporters [51]. These results suggested that chemically disabling of the MRPs resulted in
increased C. elegans susceptibility to Bcc strains. The use of mometasone and lasalocid in the
infection system increased killing rate when incubated with B. cepacia and B. dolosa, while
verapamil showed a mild effect for B. arboris.
In conclusion, this study provided tools to correlate microbial pathogenicity with the host
transporters, and highlighted specific efflux systems with a central role in Bcc virulence.
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It is worth noting that MRPs share components of a conserved activation mechanism with
the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)[57,58]. Therefore, identification of bacterial signalling molecules with substrate specificity in recognizing MRPs CFRTlike efflux transporters involved in host response could be a starting point for the development
of novel therapeutic strategies.

Supporting Information
S1 Fig. Bcc strain growth in the presence of inhibitors. For the Bcc strain growth curves in
the presence of inhibitors, one single colony of each Bcc strain was placed in a tube containing
3 mL of LB broth. The tubes were then incubated at 37°C overnight in agitation. The overnight
cultures were used to inoculate 250 mL flasks containing 50 mL of LB broth plus the inhibitors
at an initial concentration of 0.01 OD600/mL. For each strain, a set of 5 flasks was employed:
1) Verapamile 100 μM; 2) Mometasone 100 μM; 3) Lasalocid 500 nM; 4) DMSO 0.5% v/v; 5)
control (no inhibitor or DMSO). The flasks were incubated at 37°C in agitation at 220 rpm.
Bacterial growth was monitored following OD600 for 36 hours every 2 hours. The experiments
were performed in duplicate and the data reported represent mean values. Error bars were
omitted for clarity. Results proved that the inhibitors did not interfere with Bcc growth at the
concentration used in our assays, as the growth curves obtained for each strain are very similar
with no viable effect in growth by any inhibitor.
(DOC)
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